Type 2 Diabetes

Phase 3 trial demonstrates the safety and efficacy of albiglutide in type 2 diabetes patients with renal impairment…. Renal impairment is a common comorbid condition in type 2 diabetes patients with reported incidence rates as high as 35%. Those with renal insufficiency often find their diabetes treatment options limited. Possible …

Type 2 diabetes patients on a low-carb diet had improvements in physical function, pain reduction, and overall health after 12 months…. 

FREEDOM-1 and FREEDOM-1 High Baseline (HBL) study showed positive results when the continuous subcutaneous infusion of exenatide is added to standard oral diabetes medications….  ITCA 650 is a continuous subcutaneous infusion of exenatide through a pump for the treatment of type 2 diabetes. FREEDOM-1 is a double blinded, randomized, placebo-controlled, multicenter, phase …

Gout appears to increase the risk of type 2 diabetes, especially in women….  Researchers followed more than 35,000 gout sufferers in the United Kingdom and found that women with gout were 71 percent more likely to develop diabetes compared with people without gout. For men, the increased risk was 22 …

By studying identical twins, researchers have identified mechanisms that could be behind the development of type 2 diabetes…. The study involved 14 pairs of identical twins in Sweden and Denmark. One of each twin had type 2 diabetes while the other was healthy. Emma Nilsson, the researcher who carried out …

Long-term mortality of patients with ischemic heart disease is independently predicted by diabetes…. Anna Norhammar, MD, PhD, of the cardiology unit in the department of medicine at Karolinska Institutet in Sweden, said during her presentation, “Diabetes is common among patients with heart failure that report ischemic heart disease and it’s …

“An interaction of genetic risk with physical activity on incident type 2 diabetes that appears to be driven principally through genetic risk to insulin resistance.”…  Yann C. Klimentidis, PhD, of the University of Arizona Mel and Enid Zuckerman College of Public Health in Tucson, and colleagues wrote, “It has been …

No effect of tight glycemic control on mortality or major cardiovascular events in long-term follow-up of the ADVANCE trial….  The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE study) assessed the effects of routine blood-pressure lowering and strict glucose control in a broad cross …

Low HDL increases the risk of heart disease but does it also increase the risk of cancer?…

Eating a lot of higher fat dairy products seemed to lower the risk of type 2 diabetes development by up to 23%….